152 related articles for article (PubMed ID: 37195975)
41. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
42. Clinical course of thoracic cancers in Hodgkin's disease survivors.
Das P; Ng AK; Stevenson MA; Mauch PM
Ann Oncol; 2005 May; 16(5):793-7. PubMed ID: 15802277
[TBL] [Abstract][Full Text] [Related]
43. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009.
Lüchtenborg M; Riaz SP; Lim E; Page R; Baldwin DR; Jakobsen E; Vedsted P; Lind M; Peake MD; Mellemgaard A; Spicer J; Lang-Lazdunski L; Møller H
Thorax; 2014 Mar; 69(3):269-73. PubMed ID: 24172710
[TBL] [Abstract][Full Text] [Related]
44. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
[TBL] [Abstract][Full Text] [Related]
45. Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.
Ibrahim EM; Kazkaz GA; Abouelkhair KM; Al-Mansour MM; Al-Fayea TM; Al-Foheidi M; Bayer AM; Elmasri OA
Lung; 2013 Feb; 191(1):117-34. PubMed ID: 23053567
[TBL] [Abstract][Full Text] [Related]
46. Association between BMP4 expression and pathology, CT characteristics and prognosis of non-small cell lung cancer.
Ju FJ; Meng FQ; Hu HL; Liu J
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5787-5794. PubMed ID: 31298330
[TBL] [Abstract][Full Text] [Related]
47. [Prognostic Analysis of Lobectomy versus Sublobar Resection in Patients Aged ≥60 Years with Stage Ia Small Cell Lung Cancer].
Zeng H; Liu Y; Xia X; Li J; He J
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):8-15. PubMed ID: 29357967
[TBL] [Abstract][Full Text] [Related]
48. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
49. Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome.
Schoenfeld JD; Mauch PM; Das P; Silver B; Marcus KJ; Stevenson MA; Ng AK
Ann Oncol; 2012 Jul; 23(7):1813-8. PubMed ID: 22104573
[TBL] [Abstract][Full Text] [Related]
50. Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer.
Kourelis TV; Wysokinska EM; Wang Y; Yang P; Mansfield AS; Tafur AJ
Lung Cancer; 2014 Dec; 86(3):358-62. PubMed ID: 25453848
[TBL] [Abstract][Full Text] [Related]
51. Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database.
Yang L; Zhou Y; Wang G; Liu D; Chen B; Pu D; Correale P; Rades D; Tomita Y; Inno A; Santarpia M; Li Y; Li W
Transl Lung Cancer Res; 2021 Nov; 10(11):4250-4265. PubMed ID: 35004254
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
53. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years.
Johnson BE; Linnoila RI; Williams JP; Venzon DJ; Okunieff P; Anderson GB; Richardson GE
J Clin Oncol; 1995 Jan; 13(1):101-11. PubMed ID: 7799009
[TBL] [Abstract][Full Text] [Related]
54. [Exploration of the treatment model for patients with advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease based on real-world data].
Wang F; Xie XH; Lin XQ; Qin YY; Xie ZH; Zhang JX; Ouyang M; Zhou CZ
Zhonghua Jie He He Hu Xi Za Zhi; 2020 May; 43(5):450-454. PubMed ID: 32450634
[No Abstract] [Full Text] [Related]
55. The landscape of immune checkpoint inhibitor therapy in advanced lung cancer.
Wang C; Li J; Zhang Q; Wu J; Xiao Y; Song L; Gong H; Li Y
BMC Cancer; 2021 Aug; 21(1):968. PubMed ID: 34454455
[TBL] [Abstract][Full Text] [Related]
56. A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.
Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Shimizu K; Imai H; Utsugi M; Iwasaki Y; Iijima H; Tsurumaki H; Yoshii A; Fueki N; Hisada T; Ishizuka T; Saito R; Mori M
Lung Cancer; 2010 Jul; 69(1):99-104. PubMed ID: 19853960
[TBL] [Abstract][Full Text] [Related]
57. [Analysis of Correlation between TTF-1 and Sensitivity to First-line Chemotherapy and Prognosis in Patients with Small Cell Lung Cancer].
Wang B; Feng N; Shi X; Qi Q; Chi X; Song T; Li H
Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):547-553. PubMed ID: 32702788
[TBL] [Abstract][Full Text] [Related]
58. Survival difference in NSCLC and SCLC patients with diabetes mellitus according to the first-line therapy.
Nakazawa K; Kurishima K; Tamura T; Ishikawa H; Satoh H; Hizawa N
Med Oncol; 2013 Mar; 30(1):367. PubMed ID: 23307241
[TBL] [Abstract][Full Text] [Related]
59. Risk of late recurrence and/or second lung cancer after treatment of patients with small cell lung cancer (SCLC).
Szczepek B; Szymańska D; Decker E; Wasowska H; Slupek A; Rowińska-Zakrzewska E
Lung Cancer; 1994 Jul; 11(1-2):93-104. PubMed ID: 8081708
[TBL] [Abstract][Full Text] [Related]
60. Effect of Radiation Therapy on Survival in Hodgkin's Lymphoma: A SEER Data Analysis.
Master S; Koshy N; Wilkinson B; Rosen L; Mills G; Mansour R; Shi R
Anticancer Res; 2017 Jun; 37(6):3035-3043. PubMed ID: 28551642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
